Skip to main content
Erschienen in: Journal of Neurology 7/2015

01.07.2015 | Original Communication

Brainstem raphe and substantia nigra echogenicity in idiopathic REM sleep behavior disorder with comorbid depression

verfasst von: Dolores Vilas, Alex Iranzo, Claustre Pont-Sunyer, Mónica Serradell, Carles Gaig, Joan Santamaria, Eduardo Tolosa

Erschienen in: Journal of Neurology | Ausgabe 7/2015

Einloggen, um Zugang zu erhalten

Abstract

In Parkinson disease (PD), REM sleep behavior disorder (RBD) and depression may occur before the onset of parkinsonism. Transcranial sonography (TCS) shows that hyperechogenicity of the substantia nigra (SN+) and hypoechogenicity of the brainstem raphe (BR+) are frequent in PD, particularly when depression is associated. Combined SN+ and BR+ identify PD subjects in whom depression antedates parkinsonism onset. It can be speculated that SN+ and BR+ may also identify idiopathic RBD (IRBD) subjects with comorbid depression, supporting the clinical diagnosis of this mood disorder. We aimed to study the brainstem raphe and substantia nigra echogenicity and their ability to predict comorbid depression in IRBD. Seventy-two IRBD patients and 71 age and sex-matched controls underwent TCS. Depression was diagnosed by means of DSM-IV criteria. Depression was more frequent in IRBD patients than in controls (44.4 vs. 18.3 %; p = 0.001). BR+ was more frequent in depressed than in nondepressed IRBD patients (32.0 vs. 11.4 %; p = 0.050). Sensitivity of BR+ to predict depression in IRBD was 32.0 %, specificity was 88.6 %, and relative risk was 1.88. Sensitivity of SN+ to predict depression in IRBD was 72.0 %, specificity was 44.1 %, and relative risk was 1.53. Sensitivity of combined BR+ and SN+ to predict depression in IRBD was 23.1 %, specificity 97.1 %, and relative risk was 2.31. Hypoechogenicity of the brainstem raphe, particularly when combined with hyperechogenicity of the substantia nigra, detects comorbid depression in IRBD. This finding suggests that dysfunction of the serotonergic dorsal raphe may be involved in the pathophysiology of depression in IRBD.
Literatur
1.
Zurück zum Zitat Braak H, Del Tredici K, Rub U, de Vos RA, Jansen Steur EN, Braak E (2003) Staging of brain pathology related to sporadic Parkinson’s disease. Neurobiol Aging 24:197–211CrossRefPubMed Braak H, Del Tredici K, Rub U, de Vos RA, Jansen Steur EN, Braak E (2003) Staging of brain pathology related to sporadic Parkinson’s disease. Neurobiol Aging 24:197–211CrossRefPubMed
2.
Zurück zum Zitat Tolosa E, Pont-Sunyer C (2011) Progress in defining the premotor phase of Parkinson’s disease. J Neurol Sci 310:4–8CrossRefPubMed Tolosa E, Pont-Sunyer C (2011) Progress in defining the premotor phase of Parkinson’s disease. J Neurol Sci 310:4–8CrossRefPubMed
3.
Zurück zum Zitat Postuma RB, Aarslnad D, Barone P et al (2012) Identifying prodromal Parkinson’s disease: pre-motor disorders in Parkinson’s disease. Mov Disord 27:617–626CrossRefPubMed Postuma RB, Aarslnad D, Barone P et al (2012) Identifying prodromal Parkinson’s disease: pre-motor disorders in Parkinson’s disease. Mov Disord 27:617–626CrossRefPubMed
4.
Zurück zum Zitat Plomhouse L, Dujarin K, Duhamel A et al (2013) Rapid eye movement sleep behaviour disorder in treatment-naïve Parkinson disease patients. Sleep Med 14:1035–1037CrossRef Plomhouse L, Dujarin K, Duhamel A et al (2013) Rapid eye movement sleep behaviour disorder in treatment-naïve Parkinson disease patients. Sleep Med 14:1035–1037CrossRef
5.
Zurück zum Zitat Iranzo A, Santamaria J, Rye DB et al (2005) Characteristics of idiopathic REM sleep behaviour disorder and that associated with MSA and PD. Neurology 65:247–252CrossRefPubMed Iranzo A, Santamaria J, Rye DB et al (2005) Characteristics of idiopathic REM sleep behaviour disorder and that associated with MSA and PD. Neurology 65:247–252CrossRefPubMed
6.
Zurück zum Zitat Pont-Sunyer C, Hotter A, Gaig C et al (2015) The onset of nonmotor symptoms in Parkinson’s disease (The ONSET PD Study). Mov Disord 30:229–237CrossRefPubMed Pont-Sunyer C, Hotter A, Gaig C et al (2015) The onset of nonmotor symptoms in Parkinson’s disease (The ONSET PD Study). Mov Disord 30:229–237CrossRefPubMed
7.
Zurück zum Zitat Schenck CH, Boeve BF, Mahowald MW (2013) Delayed emergence of a parkinsonian disorder or dementia in 81% of older men initially diagnosed with idiopathic rapid eye movement sleep behaviour disorder: a 16-year update on a previously reported series. Sleep Med 14:744–748CrossRefPubMed Schenck CH, Boeve BF, Mahowald MW (2013) Delayed emergence of a parkinsonian disorder or dementia in 81% of older men initially diagnosed with idiopathic rapid eye movement sleep behaviour disorder: a 16-year update on a previously reported series. Sleep Med 14:744–748CrossRefPubMed
8.
Zurück zum Zitat Iranzo A, Tolosa E, Gelpi E, Molinuevo JL, Valldeoriola F, Serradell M et al (2013) Neurodegenerative disease status and post-mortem pathology in idiopathic rapid-eye-movement sleep behaviour disorder: an observational cohort study. Lancet Neurol 12:443–453CrossRefPubMed Iranzo A, Tolosa E, Gelpi E, Molinuevo JL, Valldeoriola F, Serradell M et al (2013) Neurodegenerative disease status and post-mortem pathology in idiopathic rapid-eye-movement sleep behaviour disorder: an observational cohort study. Lancet Neurol 12:443–453CrossRefPubMed
9.
Zurück zum Zitat Postuma RB, Gagnon JF, Montplaisir J (2013) Rapid eye movement sleep behaviour disorder as a biomarker for neurodegeneration: the past 10 years. Sleep Med 14:763–767CrossRefPubMed Postuma RB, Gagnon JF, Montplaisir J (2013) Rapid eye movement sleep behaviour disorder as a biomarker for neurodegeneration: the past 10 years. Sleep Med 14:763–767CrossRefPubMed
10.
Zurück zum Zitat Nilsson FM, Kessing LV, Bolwig TC (2001) Increased risk of developing Parkinson’s disease for patients with major affective disorder: a register study. Acta Psychiatr Scand 104:380–386CrossRefPubMed Nilsson FM, Kessing LV, Bolwig TC (2001) Increased risk of developing Parkinson’s disease for patients with major affective disorder: a register study. Acta Psychiatr Scand 104:380–386CrossRefPubMed
11.
Zurück zum Zitat Leentjens AFG, Van den Akker M, Metsemakers JFM, Lousberg R, Verhey FRJ (2003) Higher incidence of depression preceding the onset of Parkinson’s disease: a register study. Mov Disord 18:414–418CrossRefPubMed Leentjens AFG, Van den Akker M, Metsemakers JFM, Lousberg R, Verhey FRJ (2003) Higher incidence of depression preceding the onset of Parkinson’s disease: a register study. Mov Disord 18:414–418CrossRefPubMed
12.
Zurück zum Zitat Santamaria J, Tolosa E, Valles A (1986) Parkinson’s disease with depression: a possible subgroup of idiopathic parkinsonism. Neurology 36:1130–1133CrossRefPubMed Santamaria J, Tolosa E, Valles A (1986) Parkinson’s disease with depression: a possible subgroup of idiopathic parkinsonism. Neurology 36:1130–1133CrossRefPubMed
13.
Zurück zum Zitat Barone P, Antonini A, Colosimo C et al (2009) The PRIAMO study: a multicenter assessment of nonmotor symptoms and their impact on quality of life in Parkinson disease. Mov Disord 24:1641–1649CrossRefPubMed Barone P, Antonini A, Colosimo C et al (2009) The PRIAMO study: a multicenter assessment of nonmotor symptoms and their impact on quality of life in Parkinson disease. Mov Disord 24:1641–1649CrossRefPubMed
14.
Zurück zum Zitat Berg D, Godau J, Walter U (2008) Transcranial sonography in movement disorders. Lancet Neurol 7:1044–1055CrossRefPubMed Berg D, Godau J, Walter U (2008) Transcranial sonography in movement disorders. Lancet Neurol 7:1044–1055CrossRefPubMed
15.
Zurück zum Zitat Berg D, Behnke S, Seppi K, Godau J, Lerche S, Mahlknecht P et al (2013) Enlarged hyperechogenic substantia nigra as a risk marker for Parkinson’s disease. Mov Disord 28:216–219CrossRefPubMed Berg D, Behnke S, Seppi K, Godau J, Lerche S, Mahlknecht P et al (2013) Enlarged hyperechogenic substantia nigra as a risk marker for Parkinson’s disease. Mov Disord 28:216–219CrossRefPubMed
16.
Zurück zum Zitat Iranzo A, Stockner H, Serradell M, Seppi K, Valldeoriola F, Frauscher B et al (2014) Five-year follow-up of substantia nigra echogenicity in idiopathic REM sleep behaviour disorder. Mov Disord 29:1774–1780CrossRefPubMed Iranzo A, Stockner H, Serradell M, Seppi K, Valldeoriola F, Frauscher B et al (2014) Five-year follow-up of substantia nigra echogenicity in idiopathic REM sleep behaviour disorder. Mov Disord 29:1774–1780CrossRefPubMed
17.
Zurück zum Zitat Walter U, Hoeppner J, Prudente-Morrissey L, Horowski S, Herpertz SC, Benecke R (2007) Parkinson’s disease-like midbrain sonography abnormalities are frequent in depressive disorders. Brain 130:1799–1807CrossRefPubMed Walter U, Hoeppner J, Prudente-Morrissey L, Horowski S, Herpertz SC, Benecke R (2007) Parkinson’s disease-like midbrain sonography abnormalities are frequent in depressive disorders. Brain 130:1799–1807CrossRefPubMed
18.
Zurück zum Zitat Becker G, Struck M, Bogdahn U, Becker T (1994) Echogenicity of the brainstem raphe in patients with major depression. Psychiatry Res 55:75–84CrossRefPubMed Becker G, Struck M, Bogdahn U, Becker T (1994) Echogenicity of the brainstem raphe in patients with major depression. Psychiatry Res 55:75–84CrossRefPubMed
19.
Zurück zum Zitat Becker T, Becker G, Seufert J, Hofmann E, Lange KW, Naumann M et al (1997) Parkinson’s disease and depression: evidence for an alteration of the basal limbic system detected by transcranial sonography. J Neurol Neurosurg Psychiatry 63:590–596PubMedCentralCrossRefPubMed Becker T, Becker G, Seufert J, Hofmann E, Lange KW, Naumann M et al (1997) Parkinson’s disease and depression: evidence for an alteration of the basal limbic system detected by transcranial sonography. J Neurol Neurosurg Psychiatry 63:590–596PubMedCentralCrossRefPubMed
20.
Zurück zum Zitat Berg D, Supprian T, Hofmann E, Zeiler B, Jager A, Lange KW et al (1999) Depression in Parkinson’s disease: brainstem midline alteration on transcranial sonography and magnetic resonance imaging. J Neurol 246:1186–1193CrossRefPubMed Berg D, Supprian T, Hofmann E, Zeiler B, Jager A, Lange KW et al (1999) Depression in Parkinson’s disease: brainstem midline alteration on transcranial sonography and magnetic resonance imaging. J Neurol 246:1186–1193CrossRefPubMed
21.
Zurück zum Zitat Cho JW, Baik JS, Lee MS (2011) Mesencephalic midline change on transcranial sonography in early Parkinson disease patients with depression. J Neurol Sci 310:50–52CrossRefPubMed Cho JW, Baik JS, Lee MS (2011) Mesencephalic midline change on transcranial sonography in early Parkinson disease patients with depression. J Neurol Sci 310:50–52CrossRefPubMed
22.
Zurück zum Zitat Schmidauer C, Sojer M, Seppi K et al (2005) Transcranial ultrasound shows nigral hypoechogenicity in restless legs syndrome. Ann Neurol 58:630–634CrossRefPubMed Schmidauer C, Sojer M, Seppi K et al (2005) Transcranial ultrasound shows nigral hypoechogenicity in restless legs syndrome. Ann Neurol 58:630–634CrossRefPubMed
23.
Zurück zum Zitat American Academy of Sleep Medicine (2014) International classification of sleep disorders, 3rd edn. American Academy of Sleep Medicine, Darien American Academy of Sleep Medicine (2014) International classification of sleep disorders, 3rd edn. American Academy of Sleep Medicine, Darien
24.
Zurück zum Zitat Goetz CG, Tilley BC, Shaftman SR, Stebbins GT, Fahn S, Martinez-Martin P et al (2008) Movement disorder society-sponsored revision of the unified Parkinson’s Disease Rating Scale (MDS-UPDRS): scale presentation and clinimetric testing results. Mov Disord 23:2129–2170CrossRefPubMed Goetz CG, Tilley BC, Shaftman SR, Stebbins GT, Fahn S, Martinez-Martin P et al (2008) Movement disorder society-sponsored revision of the unified Parkinson’s Disease Rating Scale (MDS-UPDRS): scale presentation and clinimetric testing results. Mov Disord 23:2129–2170CrossRefPubMed
25.
Zurück zum Zitat American Psychiatric Association (1995) Diagnostic and statistical manual of mental disorders 4a. American Psychiatric Association, Washington, DC American Psychiatric Association (1995) Diagnostic and statistical manual of mental disorders 4a. American Psychiatric Association, Washington, DC
26.
Zurück zum Zitat Zigmond AS, Snaith RP (1983) The hospital anxiety and depression scale. Acta Psychiatr Scand 67:361–370CrossRefPubMed Zigmond AS, Snaith RP (1983) The hospital anxiety and depression scale. Acta Psychiatr Scand 67:361–370CrossRefPubMed
27.
Zurück zum Zitat Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J (1961) An inventory for measuring depression. Arch Gen Psychiatry 4:561–571CrossRefPubMed Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J (1961) An inventory for measuring depression. Arch Gen Psychiatry 4:561–571CrossRefPubMed
28.
Zurück zum Zitat Schrag A, Hosrdfall L, Walters K, Noyce A, Petersen I (2014) Prediagnostic presentations of Parkinson’s disease in primary care: a case-control study. Lancet Neurol 14:57–64CrossRefPubMed Schrag A, Hosrdfall L, Walters K, Noyce A, Petersen I (2014) Prediagnostic presentations of Parkinson’s disease in primary care: a case-control study. Lancet Neurol 14:57–64CrossRefPubMed
29.
Zurück zum Zitat Kessler RC, Birnbaum H, Bromet E et al (2010) Age differences in major depression: results from the National Comorbidity Survey Replication (NCS-R). Psaychol Med 40:225–237CrossRef Kessler RC, Birnbaum H, Bromet E et al (2010) Age differences in major depression: results from the National Comorbidity Survey Replication (NCS-R). Psaychol Med 40:225–237CrossRef
30.
Zurück zum Zitat Richards D (2011) Prevalence and clinical course of depression: a review. Clin Psycol Rev 31:117–1125 Richards D (2011) Prevalence and clinical course of depression: a review. Clin Psycol Rev 31:117–1125
31.
Zurück zum Zitat Grinberg LT, Rueb U, di Lorenzo AT, Heinsen H (2010) Brainstem pathology and non-motor symptoms of PD. J Neurol Sci 289:81–88CrossRefPubMed Grinberg LT, Rueb U, di Lorenzo AT, Heinsen H (2010) Brainstem pathology and non-motor symptoms of PD. J Neurol Sci 289:81–88CrossRefPubMed
32.
Zurück zum Zitat Walter U, Skoloduik D, Berg D (2010) Transcranial sonography findings related to non-motor features of Parkinson’s disease. J Neurol Sci 289:123–127CrossRefPubMed Walter U, Skoloduik D, Berg D (2010) Transcranial sonography findings related to non-motor features of Parkinson’s disease. J Neurol Sci 289:123–127CrossRefPubMed
Metadaten
Titel
Brainstem raphe and substantia nigra echogenicity in idiopathic REM sleep behavior disorder with comorbid depression
verfasst von
Dolores Vilas
Alex Iranzo
Claustre Pont-Sunyer
Mónica Serradell
Carles Gaig
Joan Santamaria
Eduardo Tolosa
Publikationsdatum
01.07.2015
Verlag
Springer Berlin Heidelberg
Erschienen in
Journal of Neurology / Ausgabe 7/2015
Print ISSN: 0340-5354
Elektronische ISSN: 1432-1459
DOI
https://doi.org/10.1007/s00415-015-7745-0

Weitere Artikel der Ausgabe 7/2015

Journal of Neurology 7/2015 Zur Ausgabe

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Schützt Olivenöl vor dem Tod durch Demenz?

10.05.2024 Morbus Alzheimer Nachrichten

Konsumieren Menschen täglich 7 Gramm Olivenöl, ist ihr Risiko, an einer Demenz zu sterben, um mehr als ein Vierten reduziert – und dies weitgehend unabhängig von ihrer sonstigen Ernährung. Dafür sprechen Auswertungen zweier großer US-Studien.

Bluttest erkennt Parkinson schon zehn Jahre vor der Diagnose

10.05.2024 Parkinson-Krankheit Nachrichten

Ein Bluttest kann abnorm aggregiertes Alpha-Synuclein bei einigen Menschen schon zehn Jahre vor Beginn der motorischen Parkinsonsymptome nachweisen. Mit einem solchen Test lassen sich möglicherweise Prodromalstadien erfassen und die Betroffenen früher behandeln.

Darf man die Behandlung eines Neonazis ablehnen?

08.05.2024 Gesellschaft Nachrichten

In einer Leseranfrage in der Zeitschrift Journal of the American Academy of Dermatology möchte ein anonymer Dermatologe bzw. eine anonyme Dermatologin wissen, ob er oder sie einen Patienten behandeln muss, der eine rassistische Tätowierung trägt.

Wartezeit nicht kürzer, aber Arbeit flexibler

Psychotherapie Medizin aktuell

Fünf Jahren nach der Neugestaltung der Psychotherapie-Richtlinie wurden jetzt die Effekte der vorgenommenen Änderungen ausgewertet. Das Hauptziel der Novellierung war eine kürzere Wartezeit auf Therapieplätze. Dieses Ziel wurde nicht erreicht, es gab jedoch positive Auswirkungen auf andere Bereiche.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.